Transformation of Mouse Models Revolutionizes Cancer Research

14
Jan, 2015

Transformation of Mouse Models Revolutionizes Cancer Research

  • Posted on January 14, 2015 by Pharma Models Blogging Team in Oncology

Cancer research has advanced tremendously over the years due to the significant benefits of mouse model studies. However, it has taken longer than anticipated to develop cancer drugs that are both effective in animal models and human clinical trials. Cancer research has only a 10 percent success rate of drugs that are both compelling in […]

17
Dec, 2014

The FDA Streamlines Approval Process and Improves Cancer Drug Development

  • Posted on December 17, 2014 by Pharma Models Blogging Team in Oncology

Scientists have spent the last century developing better cancer treatments and uncovering causes of tumor growth in order to save lives. However, today the U.S.-based scientific community is able to do little without the approval of the Food and Drug Administration (FDA). Luckily, the FDA has recently moved forward in enhancing cancer treatments and research […]

26
May, 2014

Four Tumor Models Vital in Our Search for a Cancer Cure

  • Posted on May 26, 2014 by Pharma Models Blogging Team in Oncology

Many early steps in cancer research began in either animal or tumor models. Without these prototypes, researchers would not have been able to create effective drug treatments or find a cure. In the 1960s, the earliest in vivo tumor models were developed, which were ascites models or murine leukemia models. A paper published in the […]

13
May, 2014

Animal Testing Significantly Advances Cancer Research

  • Posted on May 13, 2014 by Pharma Models Blogging Team in Oncology

Today, patients who are diagnosed with cancer have a much higher likelihood of survival than in decades past. Fifty or sixty years ago, cancer was nearly always assigned a death sentence. Scientific cancer research, however, has brought effective treatments and increased the lifespan of most cancer patients. The advances that we have seen would not […]